xcellbio

About

Xcell Biosciences, founded in 2012 and based in San Francisco, California, is a biotechnology company focused on advancing cell and gene therapies. The company operates additional facilities in Melbourne and specializes in innovative instrumentation, AI-driven software, and cGMP manufacturing platforms. Xcellbio develops technologies that enhance the performance and safety of cell therapies, particularly for solid tumors, by addressing challenges posed by immunosuppressive tumor microenvironments. The company offers several key products, including the AVATAR Incubator System for cell therapy research, the AVATAR Foundry for scalable cGMP-compliant manufacturing, and AI-driven tools for measuring cell therapy potency. Xcellbio provides integrated solutions for automated manufacturing processes and collaborates with industry leaders like Labcorp and AmplifyBio to optimize cell therapy production. Its mission is to enable researchers to gain insights into immune and tumor biology while facilitating the transition from research to patient-level production.